SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-06-051493
Filing Date
2006-08-04
Accepted
2006-08-04 13:55:25
Documents
7
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a06-15388_110q.htm 10-Q 787321
2 EX-10 a06-15388_1ex10d35.htm EX-10.35 107531
3 EX-10 a06-15388_1ex10d36.htm EX-10.36 176378
4 EX-31 a06-15388_1ex31d1.htm EX-31.1 10287
5 EX-31 a06-15388_1ex31d2.htm EX-31.2 10354
6 EX-32 a06-15388_1ex32.htm EX-32 10774
7 GRAPHIC g153881kc01i001.jpg GRAPHIC 2709
  Complete submission text file 0001104659-06-051493.txt   1108015
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 061005169
SIC: 2834 Pharmaceutical Preparations